Wei Wu
12Patents
4h-index
10Co-inventors
53Inventor score
Filing activity: Apr 28, 2010 → May 21, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8215299B2 | Counter for metered dose inhaler | Human Necessities | 10 | Active |
| US11324963B2 | Brain stimulation treatment in depression | Human Necessities | 6 | Active |
| US11577090B2 | Machine learning based artifact rejection for transcranial magnetic stimulation electroencephalogram | Human Necessities | 6 | Active |
| USD838835S1 | Inhaler | General | 5 | Active |
| US9241904B1 | Method for preparing metered dose sprayed inhaler for treating respiratory disease | Performing Operations; Transporting | 1 | Active |
| US12383196B2 | Treatment of depression using machine learning | Physics | 0 | Active |
| US12115383B2 | Brain stimulation treatment in depression | Human Necessities | 0 | Active |
| US12233059B2 | Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent | Human Necessities | 0 | Active |
| US8877740B2 | Compound composition for inhalation used for treating asthma | Human Necessities | 0 | Active |
| US12226375B1 | Method of treatment and selection of patients benefiting from agomelatine based on EEG measurements | Human Necessities | 0 | Active |
| US12263011B2 | Treatment of depression using machine learning | General | 0 | Revoked |
| US12208096B2 | Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.